Akcea Therapeutics Inc logo

AKCA - Akcea Therapeutics Inc News Story

$17.92 0.8  4.8%

Last Trade - 26/02/20

Sector
Healthcare
Size
Mid Cap
Market Cap £1.23bn
Enterprise Value £1.04bn
Revenue £170.1m
Position in Universe 2021st / 6407

BRIEF-Akcea Says Retained Rights To Develop And Commercialize AKCEA-APOCIII-LRX

Thu 19th December, 2019 3:30am
Dec 18 (Reuters) - Akcea Therapeutics Inc  AKCA.O :
    * AKCEA-FOLLOWING STRATEGIC PORTFOLIO DECISION BY NOVARTIS
NOT TO
EXERCISE ITS OPTION, CO RETAINED RIGHTS TO DEVELOP AND
COMMERCIALIZE AKCEA-APOCIII-LRX

Source text for Eikon:  ID:nGNXb5YvPP 
Further company coverage:  AKCA.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.